Aridis Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Aridis Pharmaceuticals's estimated annual revenue is currently $2.8M per year.
- Aridis Pharmaceuticals's estimated revenue per employee is $174,375
- Aridis Pharmaceuticals's total funding is $67.1M.
Employee Data
- Aridis Pharmaceuticals has 16 Employees.
- Aridis Pharmaceuticals grew their employee count by 0% last year.
Aridis Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Research and Development | Reveal Email/Phone |
3 | VP Clinical Development | Reveal Email/Phone |
4 | VP, Quality | Reveal Email/Phone |
5 | VP Finance | Reveal Email/Phone |
6 | VP Regulatory Affairs and Quality | Reveal Email/Phone |
7 | Sr. Director, Clinical Data Management | Reveal Email/Phone |
8 | Associate Director - Drug Supply for Aridis Pharmaceuticals Inc. | Reveal Email/Phone |
9 | Director R&D | Reveal Email/Phone |
10 | Director R&D | Reveal Email/Phone |
Aridis Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Aridis Pharmaceuticals?
Aridis Pharmaceuticals, LLC is a private biologics development company formed in 2003 using formulation and delivery technologies to produce differentiated, high value products. Our initial products target infectious diseases that have a significant impact on life expectancy, such as infectious diseases in children and cystic fibrosis (CF) in adults and children. Aridis has three licensed products: two with preclinical data, and one with phase II clinical efficacy data.
keywords:N/A
$67.1M
Total Funding
16
Number of Employees
$2.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aridis Pharmaceuticals News
Aridis Pharmaceuticals, Inc, a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using...
KalVista Pharmaceuticals (NASDAQ:KALV) versus Aridis Pharmaceuticals (NASDAQ:ARDS) Head-To-Head Analysis. Posted by admin on Apr 16th, 2022.
Aridis Pharmaceuticals, Inc. discovers and develops anti-infectives to be used as first-line treatments to combat antimicrobial resistance (AMR)...
Aridis Pharmaceuticals Announces Third Quarter 2021 Results Executed AstraZeneca in-licensing deal of Phase 3-ready antibody, suvratoxumab, in July 2021 Bolstered financial position with approx. $25 million in equity financing in August 2021 LOS GATOS, Calif., November 10, 2021 /PRNewswire/ - ...
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 16 | 7% | $30M |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $1.3M | 16 | N/A | N/A |
#4 | $1.3M | 16 | N/A | N/A |
#5 | $2.4M | 16 | N/A | N/A |